Serina Therapeutics Inc (SER)

概要ニュース株価時系列ディスカッション予測

Serina Therapeutics Inc (SER) 最新ニュース

Serina Therapeutics Inc (SER)

Serina Therapeutics Inc (SER) 最新ニュース

Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewswire

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - The Manila Times

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan - GlobeNewswire Inc.

TSX Composite Capped Index (TOOC) QuotePress Release - The Globe and Mail

AgeX Therapeutics stock hits 52-week low at $5.72 - Investing.com India

AgeX Therapeutics stock hits 52-week low at $5.72 By Investing.com - Investing.com Canada

Serina Therapeutics CDO Presents at Injectables Summit - TipRanks

Serina Therapeutics to Present at the 14th Annual Injectables Summit - GlobeNewswire

SLM initiated with a Buy at BofA - TipRanks

Serina Therapeutics director buys $6.9k in company stock By Investing.com - Investing.com Australia

Serina Therapeutics director buys $6.9k in company stock - Investing.com India

Biotech Soars On Material Transfer Agreement - Invezz

TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail

Seelos Therapeutics Inc Inc. (SEEL) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

Savaria (TSE:SIS) Trading Down 4.1% - MarketBeat

SThree Q3 net fees slip 8% amid challenging conditions - Staffing Industry Analysts

UK recruiter SThree falls on lower Q3 net fee - XM

SThree plc Navigates Market Headwinds in Q3 - TipRanks

Serabi Gold (LON:SRB) Reaches New 12-Month High at $91.97 - MarketBeat

Quarterly Metrics: Quick and Current Ratios for SELLAS Life Sciences Group Inc (SLS) - The Dwinnex

Ready to Jump After Recent Trade: SELLAS Life Sciences Group Inc (SLS) - SETE News

Sanofi's Sarclisa Secures FDA Approval For First-Line Multiple Myeloma, Marking Its Third US Approval - Benzinga

Director Gregory Bailey Acquires 14,388 Shares of Serina Therapeutics Inc (SER) - Stockxpo

Serina Therapeutics director buys $88.2k in company stock By Investing.com - Investing.com South Africa

Serina Therapeutics director buys $88.2k in company stock - Investing.com

Sanofi (NASDAQ: SNY) Secures FDA Approval for Multiple Myeloma Drug in Newly Diagnosed Patients - ABBO News

Serina Therapeutics appoints new CEO with strategic goals By Investing.com - Investing.com Australia

Serina Therapeutics appoints new CEO with strategic goals - Investing.com

Serina Therapeutics Names Steven Ledger as Permanent CEO - TipRanks

Serina Therapeutics Interim CEO Attends Global Investment Conference - TipRanks

Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Serina Therapeutics director buys $14.7k in company stock - Investing.com

Serina Therapeutics director buys $140k in company stock - Investing.com India

Director Gregory Bailey Acquires 19,200 Shares of Serina Therapeutics Inc (SER) - Yahoo Finance

Serina Therapeutics director buys $45k in company stock - Investing.com

Serina Therapeutics Welcomes Gregory Curhan as New CFO - TipRanks

Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights - GlobeNewswire

Nima Farzan named CEO of Latigo - BioCentury

Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation - GlobeNewswire

Injectable Drug Delivery Market Size to Hit USD 1,630.73 Bn by 2033 - BioSpace

Enable Injections makes C-suite move following slew of new partnershipsCincinnati Business Courier - Cincinnati Business Courier

Enable Injections & Serina Partner to Develop Novel Parkinson’s Treatment - HIT Consultant

Enable Injections and Serina Therapeutics Announce - GlobeNewswire

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights - Yahoo Finance

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman - GlobeNewswire

Why VirTra Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving PremarketVirTra (NASDAQ:VTSI) - Benzinga

Serina completes AgeX merger, targets neurological diseases and pain - Longevity.Technology

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics - GlobeNewswire

AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial Results - Yahoo Finance

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc.AGE - Business Wire

AgeX Therapeutics Postpones Merger Completion with Serina - TipRanks

Pfizer licenses small molecule drug delivery technology from Serina - Pharmaceutical Technology

Serina Therapeutics Announces POZ Polymer Technology License Agreement with Pfizer - Yahoo Finance

AgeX Therapeutics Reports Third Quarter 2023 Financial Results - Business Wire

SERに似た銘柄